Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Cor
(NQ:
EXAS
)
69.06
+2.18 (+3.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Exact Sciences Cor
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Today 6:00 EDT
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
March 27, 2024
From
Exact Sciences Corp.
Via
Business Wire
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
March 13, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
March 07, 2024
From
Exact Sciences Corp.
Via
Business Wire
3 Hot Stocks Bought by Members of Congress: Follow the Money
March 01, 2024
Palo Alto Networks, Simon Property Group and JPMorgan Chase are the top three stocks bought by Members of Congress in February;
Via
MarketBeat
Exact Sciences to Participate in March Investor Conference
February 26, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Announces Fourth Quarter 2023 Results
February 21, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Schedules Fourth Quarter 2023 Earnings Call
February 01, 2024
From
Exact Sciences Corp.
Via
Business Wire
Time to buy these 3 healthcare companies that raised revenue guidance?
January 16, 2024
The new year brings a clean slate heading into the fourth-quarter earnings season. Check out a few companies that have raised revenue guidance.
Via
MarketBeat
Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
September 12, 2023
From
Agilent Technologies Inc.
Via
Business Wire
ARKK: The Pros and Cons Of Buying Into Cathie's Best-Known ETF
July 13, 2023
If you're a believer in the progress of science and technology and feel strongly that our best days are still ahead, then a slice of ARKK could be tempting.
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
Analysts Bullish On Exact Sciences' Advanced Cancer Screening
June 23, 2023
Exact Sciences sees a bump in stock price amid rising revenue and study results that show advancements to its flagship Cologuard colorectal screening product.
Via
MarketBeat
MarketBeat Week in Review – 5/15 - 5/19
May 20, 2023
Investors are battling stagflation as they wait for a recession, and the MarketBeat team continues to help you understand where to find opportunities
Via
MarketBeat
Topics
Economy
Electric Vehicles
Exposures
Economy
Electric Vehicles
Interest Rates
Exact Sciences Serves Investors Exactly What They Wished For
May 15, 2023
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The
Via
MarketBeat
A New Groundbreaking Tool to Detect Colon Cancer Earlier
May 10, 2023
A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This...
Via
PressReach
Exposures
Product Safety
New Artificial Intelligence Tool Can Diagnose Colon Cancer
May 03, 2023
A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and...
Via
PressReach
Topics
Artificial Intelligence
Death
Exposures
Artificial Intelligence
Death
Product Safety
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.
Via
MarketBeat
Topics
ETFs
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
February 02, 2023
Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023?
Via
MarketBeat
Topics
ETFs
Cathie Wood Is Buying These Stocks, Should You?
January 18, 2023
Cathie Wood is known for her deep understanding of tech companies and for holding aggressive long positions in her tech funds. Let's look at what she's buying.
Via
MarketBeat
Topics
ETFs
Exact Sciences Corp Stock Price Is Trending Up Here's Why
January 10, 2023
Exact Science's stock price is shooting higher this week amid posting upward revisions for its revenue and earnings estimates for this quarter.
Via
MarketBeat
Is Illumina Still the Gamechanger in Genomics Sequencing?
October 04, 2022
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused
Via
MarketBeat
Topics
Earnings
Economy
Lawsuit
Exposures
Financial
Legal
Supply Chain
Mainz Biomed (MYNZ) nominates two notable leaders in key areas of the diagnostics field to its Board of Directors
September 29, 2022
Via
AB Newswire
Billions Flowing into Cancer Immunotherapy as Market Responds to Impressive Market Potential
January 24, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 24, 2022 – USA News Group – Within the grand battle against cancer, the use of immunotherapy continues to grow at...
Via
FinancialNewsMedia
Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer
February 02, 2022
Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials...
Via
FinancialNewsMedia
Rising Cases of Early-Onset Colorectal Cancer Calls for Expanded Biotech Screening Methods
December 01, 2021
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – December 1, 2021 – Early onset colorectal cancer is currently on the rise [[1]], according to a new study [[2]] from the...
Via
FinancialNewsMedia
Earlier Screening and Aging Population Driving Surging Growth in Colorectal Diagnostics Demand
November 11, 2021
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force...
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.